Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are an adult with advanced (stage III or IV) melanoma, or a skin cancer (squamous cell or basal cell carcinoma) that cannot be removed by surgery
- For the retrospective group (looking back at past treatment): you have already been receiving a specific type of immunotherapy (anti-PD1, with or without other similar drugs) for your skin cancer for at least 90 days, with at least 6 months of follow-up recorded
- For the prospective group (following you going forward): you are about to start the same type of immunotherapy for your skin cancer and have not previously received it for this condition
- Any previous similar immunotherapy given after surgery is acceptable, as long as it was stopped at least 6 months before your current treatment began
- A previous treatment called interferon is acceptable if it was also stopped at least 6 months before your current treatment
- Previous targeted therapy (a specific type of cancer drug) before starting immunotherapy is acceptable
- Previous radiotherapy may be acceptable depending on where it was given (confirm with trial site)
- You have agreed to take part in the research and have signed a form allowing your images to be used
Who may not be able to join:
- You have received the relevant immunotherapy treatment for less than 90 days (retrospective group only)
- You received a type of immunotherapy after surgery within the 6 months before starting your current treatment
- You received chemotherapy before starting your current immunotherapy treatment
- Your original skin cancer is located in a place that cannot be photographed, such as inside the eye or on certain mucous membranes (some exceptions may apply — confirm with trial site)
- You were taking steroid tablets at a dose greater than 10 mg per day when you started immunotherapy
- You have a weakened immune system due to another condition, such as HIV, a blood disorder, or because you have had an organ transplant
- You have a skin condition called vitiligo that developed around your surgery scar as a result of previous treatment
- You have chosen not to take part in the research
- You are an adult who is legally protected (for example, under guardianship) (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33240083116
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predictive performance of tumor progression score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.